Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Irinotecan × 1 year × Clear all

Phase

Status

Sponsor Class

OTHER 108 INDUSTRY 57 NETWORK 12 NIH 8 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Capecitabine 8 Oxaliplatin 7 Drug Therapy 7 tislelizumab 6 Surgical Procedures, Operative 6 Bevacizumab 6 pembrolizumab 5 Saline Solution 5 Fluorouracil 5 Docetaxel 5 Cisplatin 5 Carboplatin 5 Standard of Care 4 Radiosurgery 4 Gemcitabine 4 Exercise 4 Control Groups 4 Tranexamic Acid 3 Radiotherapy 3 Paclitaxel 3 Nivolumab 3 Metformin 3 Mammography 3 Leucovorin 3 Laparoscopy 3 Epirubicin 3 Endoscopic Mucosal Resection 3 Cyclophosphamide 3 sintilimab 2 human papillomavirus vaccine, L1 type 16, 18 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04776655 2025-10-02

LIBImAb

Azienda USL Reggio Emilia - IRCCS

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡